Factors affecting the postoperative survival rate of obese Asian patients with endometrial cancer
- PMID: 40135557
- DOI: 10.1080/01443615.2025.2480856
Factors affecting the postoperative survival rate of obese Asian patients with endometrial cancer
Abstract
Background: The objective of this study was to explore the factors that influence overall survival in obese patients with endometrial cancer (EC).
Methods: The retrospective study included patients with EC who were treated between 2000 and April 2013. Subjects were divided into the following groups based on body mass index (BMI): non-obese (<24.0 kg/m2), overweight (24.0-28.0 kg/m2) and obese (>28.0 kg/m2). Survival data were estimated using Kaplan-Meier's curves and compared using log-rank statistics.
Results: A total of 280 cases were enrolled, including 22.5% in non-obese group, 42.9% in overweight group and 34.6% in obese group. Among different BMI groups, obese EC patients with diabetes have a lower survival rate (p = .041), and obese EC patients with menopause have a lower survival rate (p = .021). The survival rate of overweight EC patients was significantly reduced if vascular thrombus and lymph node metastasis were found during operation (p < .001).
Conclusions: Our data suggest that the association of obese EC patients with menstrual status, diabetes and intraoperative vasculature embolus and lymph node metastasis significantly affects postoperative survival. In all subjects, the relevant factors were independent prognostic factors in patients with obese.
Keywords: Endometrial cancer; obesity; survival rate.
Plain language summary
This study investigated factors affecting survival in Asian obese endometrial cancer patients. We studied patients between 2000 and 2013, and grouped them into non-obese, overweight and obese. Using Kaplan–Meier’s curves and log-rank tests, the study found that obese patients with diabetes or menopause had lower survival rates. Obese patients had significantly reduced survival if vascular thrombus or lymph node metastasis was detected during surgery. These factors were identified as independent prognostic indicators in obese patients.
Similar articles
-
Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI.Gynecol Oncol. 2016 Mar;140(3):405-8. doi: 10.1016/j.ygyno.2016.01.020. Epub 2016 Jan 20. Gynecol Oncol. 2016. PMID: 26801939
-
Severe Obesity Impacts Recurrence-Free Survival of Women with High-Risk Endometrial Cancer: Results of a French Multicenter Study.Ann Surg Oncol. 2015 Aug;22(8):2714-21. doi: 10.1245/s10434-014-4295-0. Epub 2014 Dec 12. Ann Surg Oncol. 2015. PMID: 25503347
-
Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients.Future Oncol. 2015;11(4):607-15. doi: 10.2217/fon.14.247. Future Oncol. 2015. PMID: 25686116
-
Adherence to ESGO guidelines and impact on survival in obese patients with endometrial cancer: a multicentric retrospective study.Int J Gynecol Cancer. 2023 Dec 4;33(12):1950-1956. doi: 10.1136/ijgc-2023-004642. Int J Gynecol Cancer. 2023. PMID: 37788899 Review.
-
Impact of obesity in the identification of the sentinel lymph node in endometrial cancer: a retrospective, monocentric study and literature review.Arch Gynecol Obstet. 2024 Jun;309(6):2779-2788. doi: 10.1007/s00404-024-07386-5. Epub 2024 Feb 24. Arch Gynecol Obstet. 2024. PMID: 38400908 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous